Catalyst Wire Dossier Catalyst Wire Dossier

Allogenic adipose tissue-derived mesenchymal progenitor cells

· Shanghai AbelZeta Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogenic adipose tissue-derived mesenchymal progenitor cells, covering 2023-08-01 to 2023-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis [Phase 2]

See pricing